Health care industry

Eli Lilly expects FDA call on Zepbound for sleep apnea in near term

Health
Rachel Carter

Also on Friday, the company released additional data from two late-stage trials showing that Zepbound helped resolve obstructive sleep apnea, or OSA, ...

FDA approves Merck pneumococcal disease vaccine designed for adults

Business
Jessica Roberts

Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug Administration on Monday approved Merck‘s new vaccine ...

Scientists develop ultra-thin battery that could be charged by tears

Technology
Michael Johnson

Scientist Lee Seok Woo said a scene from a “Mission Impossible” movie inspired his latest invention: batteries for smart contact lenses. In ...

FDA approves Moderna RSV vaccine for seniors

Business
Jessica Roberts

The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine ...

Pfizer lung cancer drug shows promising long-term trial results

Business
Jessica Roberts

Lorbrena is already approved in the U.S. for treating adults with advanced non-small cell lung cancer who have a mutation in a ...

Digital health companies are launching programs around GLP-1s

Health
Rachel Carter

Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at ...

Neuralink competitor Precision Neuroscience testing human brain implant

Technology
Michael Johnson

On this particular morning in April, Bederson was readying for a meningioma resection case, which meant he would be removing a benign ...

New Covid FLiRT variants spark concerns of a summer spike

Health
Rachel Carter

Woman wearing face masksto protect against Covid-19 on 7th April 2024 in London, United Kingdom. Mike Kemp | In Pictures | Getty ...

Moderna says RSV vaccine FDA approval delayed to end of May

Business
Jessica Roberts

Investors are watching the upcoming approval closely as Moderna tries to rebound from the rapid decline of its Covid business last year. ...

Neuralink says its first in-human brain implant encounters problem

Technology
Michael Johnson

In January, Neuralink implanted the device in a 29-year-old patient named Noland Arbaugh as part of a study to test its safety. ...